Maxat Doskhanov

Maxat Doskhanov

Auto-generated profile, based on publicly available information

Maxat Doskhanov

National Scientific Center for Surgery named after A.N. Syzganov

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in BULLETIN OF SURGERY IN KAZAKHSTAN
Verified
Journal Article
Closed access
DMD.Y. Mukazhanov
D.Y. Mukazhanov
BBB.B. Baimakhanov
B.B. Baimakhanov
MDM.O. Doskhanov
M.O. Doskhanov
MAM.A. Asan
M.A. Asan
ACA.T. Chormanov
A.T. Chormanov
ZRZh.V. Romanova
Zh.V. Romanova
A systematic review of the publication, on the topic of diagnosis and treatment of inoperable alveolar echinococcosis of the liver over the past 30 years, to study the effectiveness of various methods of treatment of inoperable alveococcosis of the liver. We conducted a systematic search of literary data and selected sources from Google Scholar, PubMed, as well as research papers and online educational publications in English and Russian. Our literature review included 120 papers in which, according to the authors with inoperable liver alveococcosis, 883 patients were described, out of 120 articles: 29 full articles, 23 literary reviews, 68 clinical cases described. The authors of the articles were from various countries, such as Turkey (26%), France (24%), Germany (20%), China (18%), England (6%), Japan (5%) and other countries in Europe and Asia.

1 June 2023 in BULLETIN OF SURGERY IN KAZAKHSTAN
Verified
Journal Article
Closed access
STS.T. Tileuov
S.T. Tileuov
ADA.T. Dzhumabekov
A.T. Dzhumabekov
BBB.B. Baimakhanov
B.B. Baimakhanov
MDM.O. Doskhanov
M.O. Doskhanov
ACA.T. Chormanov
A.T. Chormanov
BAB.T. Askeev
B.T. Askeev
The purpose of research is to determine the feasibility of laparoscopic pancreatoduodenectomy in tumors of the periampullary zone. Material and methods. In the period from 2016 to 2022 at the Syzganov National Scientific Center of Surgery, 193 patients underwent PD with a diagnosis of a tumor of the periampullary zone. Of these, 6 patients were performed laparoscopically. All patients who underwent LPD were female. The age of the patients ranged from 15 to 77 years (average age – 55,7 years). Results. In 4 (66.7%) patients, cancer of Ampulla of Vater was detected, in 2 (33.3%) pancreatic head cancer. According to the final histology data, adenocarcinoma and the degree of differentiation G2 were detected in all cases. Data on the histology and size of the tumor are summarized in Table 1. The average age of patients was 55.7 years. All patients had a clinic of mechanical jaundice before surgery; the average levels of bilirubin in the blood were 121.3 mmol/l. Accordingly, all patients underwent drainage of the biliary tract. Of these, 5 (83.3%) patients underwent percutaneous stenting and 1 (16.7%) endobiliary stenting. Conclusion. Thus, we presented our initial experience of performing laparoscopic PD. Our results shows the feasibility of laparoscopic PD safely and radically for tumors of the periampullary zone in certain cases. The accumulation of experience in such interventions leads to an improvement in immediate results and a reduction in postoperative complications, the operative time.

1 October 2025 in BULLETIN OF SURGERY IN KAZAKHSTAN
Verified
Journal Article
Closed access
ASAlmaty Syzganov National Scientific Center Of Surgery
Almaty Syzganov National Scientific Center Of Surgery
BBB Baimakhanov
B Baimakhanov
SKSh Kaniyev
Sh Kaniyev
MDM Doskhanov
M Doskhanov
AJA Jumabaeva
A Jumabaeva
MTM Tursynbay
M Tursynbay
Today, hepatitis B virus-associated acute liver failure remains the leading cause of liver failure (44% mortality in Asia and 41% in the United States). Studies show that among patients with hepatitis B-associated cirrhosis, acute liver failure develops in 10-20% of cases. Acute liver failure on chronic liver disease is a potentially reversible syndrome that occurs in patients with cirrhosis or chronic liver disease and is characterized by acute decompensation, organ failure, and high short-term mortality. Chronic hepatitis B virus infection is a leading cause of liver morbidity and mortality worldwide. When we talk about hepatitis B, there is a high risk of developing super infection hepatitis D, since hepatitis D remains infectious and can reactivate at very low titers that are not detected using modern analysis methods if HBsAg remains in the blood serum. The interaction of these viruses leads to accelerated progression of fibrosis and cirrhosis of the liver, which significantly increases the risk of developing acute liver failure against the background of chronic. In our case, a patient diagnosed with liver cirrhosis as a result of viral hepatitis B with delta agent, class C according to Child–Pugh–Turcotte, MELD-36 points, the patient developed a severe form of acute renal failure, which required emergency intervention, so he was not included in the waiting list for a transplant from a cadaveric donor. His wife became the donor, which is an example of living donation, which provides higher chances of successful recovery due to a shorter waiting time and a lower risk of graft rejection. Timely examination of the donor and recipient, as well as prompt liver transplantation, contributed to a favorable outcome of the disease.

31 December 2025 in BULLETIN OF SURGERY OF KAZAKHSTAN
Verified
Journal Article
Closed access
MTM Tursynbay
M Tursynbay
MDM Doskhanov
M Doskhanov
ZOZ Ospan
Z Ospan
BBB Baimakhanov
B Baimakhanov
SKS Kaniyev
S Kaniyev
ACA Chormanov
A Chormanov
Background: Small-for-size syndrome is one of the major causes of graft dysfunction after living donor liver transplantation in adults. Excessive portal inflow leading to sinusoidal hyperperfusion and impaired graft function is the primary mechanism of this complication. Effective prevention requires not only morphometric evaluation of the graft but also strict control of portal hemodynamics. Aim of the study is evaluate the effectiveness of graft inflow modulation and determine the prognostic significance of graft-to-recipient weight ratio, spleen-to-graft volume ratio, portal venous flow, and portal venous pressure. Materials and Methods: This study included adult patients who underwent living donor liver transplantation from 2011 to 2025. Portal hemodynamics was assessed intraoperatively. Graft inflow modulation was performed upon detection of portal hyperperfusion( p< 0.05). Results: Patients with small graft volume demonstrated elevated portal venous flow and pressure prior to intervention. Inflow modulation effectively reduced portal venous pressure to physiological levels and was associated with a lower incidence of small-for-size syndrome and reduced mortality. A spleen-to-graft volume ratio greater than 1.0 was linked to significant hyperperfusion and poorer clinical outcomes. Intraoperative modulation proved markedly more effective than delayed postoperative interventions, resulting in higher survival rates and an absence of severe graft dysfunction. Conclusion: Excessive portal inflow is the key determinant of graft dysfunction in living donor liver transplantation. Timely intraoperative modulation of portal blood flow improves hemodynamic stability and enhances survival. A combined assessment of morphometric and hemodynamic parameters enables optimal prevention of small-forsize syndrome and supports a personalized transplantation approach.

31 March 2026 in BULLETIN OF SURGERY OF KAZAKHSTAN
Verified
Journal Article
Closed access
MSM Suyerkulov
M Suyerkulov
BBB Baimakhanov
B Baimakhanov
SKS Kaniyev
S Kaniyev
MDM Doskhanov
M Doskhanov
ACA Chormanov
A Chormanov
AAA Abdiev
A Abdiev
Background: Laparoscopic liver resection is a minimally invasive procedure that offers reduced surgical trauma, decreased blood loss, and faster recovery compared with open liver surgery. This study evaluated clinical safety and effectiveness of laparoscopic liver resection in a high-volume surgical center. Materials and Methods: A retrospective review included 471 liver resections carried out from 2017 to April 2025. The cohort consisted of 107 laparoscopic operations and 364 open operations. Patient demographic characteristics, operative parameters, postoperative hospital stay, and complication rates were analyzed. Surgical indications comprised echinococcosis, alveococcosis, focal nodular hyperplasia, hepatic hemangioma, hepatocellular carcinoma, metastatic liver tumors, cystadenoma, and polycystic liver disease. Results: Laparoscopic surgery showed significantly shorter operative duration (224.5 minutes versus 380 minutes), reduced intraoperative blood loss (147 milliliters versus 293 milliliters), and shorter hospitalization (5.3 days versus 10 days). Postoperative complications occurred in 0.9 percent after laparoscopic procedures and in 4.1 percent after open procedures. No deaths were recorded following laparoscopic surgery, while postoperative mortality in the open group reached 1.37 percent. Laparoscopic liver resection was predominantly used for atypical peripheral liver resections and resections of the left lateral section, whereas major and extended liver resections remained more common with open access. Conclusion: Laparoscopic liver resection demonstrated high safety, favorable perioperative outcomes, and strong clinical effectiveness, supporting further expansion of minimally invasive approaches in hepatobiliary surgery.

27 September 2026 in Electronic Journal of General Medicine
Verified
Journal Article
Open access
PDF file
ZOZhambyl Ospan
Zhambyl Ospan
MDMaxat Doskhanov
Maxat Doskhanov
BBBolatbek Baimakhanov
Bolatbek Baimakhanov
RERemzi Emiroglu
Remzi Emiroglu
SKShokan Kaniyev
Shokan Kaniyev
IFIldar Fakhradiyev
Ildar Fakhradiyev
In right-lobe living-donor liver transplantation (LDLT), adequate venous outflow of the anterior sector (V5/V8 tributaries) is critical to prevent congestion and early graft dysfunction. The choice of conduit for V5/V8 outflow reconstruction with creation of a neo-middle hepatic vein (MHV) remains a practical limitation, especially in the setting of a shortage of deceased-donor vascular allografts. The aim of this study was to describe the technical feasibility and early patency of a modified allogeneic great saphenous vein (GSV) cold-stored in custodiol and to explore its outcomes relative to recipient portal vein and prosthetic conduit cohorts. We conducted a retrospective single-center comparative cohort study covering the period from 2014 to 2025. Adult recipients aged 18-60 years who underwent right-lobe LDLT with V5 and/or V8 outflow reconstruction using a neo-MHV conduit were included: recipient PV (n = 63), prosthesis (n = 11), modified GSV (n = 16). The primary endpoint was obstruction of the re-constructed V5/V8 outflow through the neo-MHV conduit within 45 days, classified as early (≤ 7 days) or late ( > 7 days). Patency was assessed by serial Doppler ultrasound and/or contrast-enhanced imaging. Time-to-event analysis was performed using the Kaplan-Meier method. Overall outflow obstruction within 45 days was observed in 25.4% of the recipient PV group, 45.5% of the prosthesis group, and 6.2% of the modified GSV group (p = 0.063). In an exploratory Firth logistic regression adjusted for calendar year and selected baseline and graft characteristics, the overall association between conduit type and 45-day outflow obstruction was not statistically significant (p = 0.318). The probability of obstruction-free patency on day 7 was 0.804, 0.727, and 0.938, respectively; by day 45, it was 0.733, 0.468, and 0.938, respectively. Observed group-level differences included shorter cold ischemia time (38 [35; 42] min; p = 0.001), a shorter anhepatic period (42 [26; 61] min; p < 0.001), and lower blood loss (1,200 [775; 1,500] mL; p = 0.006) in the modified GSV group. Postoperative hospital stay was also shorter (18 [15; 21] days; p = 0.011), and peak AST, ALT, and INR values were lower (p = 0.039, p = 0.021, and p = 0.027, respectively). The rate of any postoperative complications did not differ significantly (p = 0.439). In-hospital mortality was 19.0% in the recipient PV group, 36.4% in the prosthesis group, and 0% in the modified GSV group (p = 0.053). In this retrospective and temporally heterogeneous cohort, modified allogeneic GSV was technically feasible and demonstrated encouraging early neo-MHV conduit patency. Because conduit allocation was non-random, the groups were small and noncontemporaneous, and important baseline and procedural differences were present, the observed associations cannot be attributed to conduit materi-al and do not establish superiority. Further prospective evaluation is warranted.